Low import drug pricing may hamper entry of new drugs.

Published: 1999-06-10 18:06:00

Updated: 1999-06-10 18:06:00

Due to unreasonable price policy on the imported drugs currently proceeded in the government a new drug especially in use of difficult diseases seems hardly to be introduced into Korean market. The government insurance price on imported drugs remains merely at 54% lower from the G7 countries, and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK